Related Experiment Video
Updated: Aug 11, 2026

12:13
Multi-unit Recording Methods to Characterize Neural Activity in the Locust (Schistocerca Americana) Olfactory Circuits
Published on: January 25, 2013
Octopamine receptors in locust nervous tissue
Biochemical Pharmacology
|June 1, 1990
Summary
Researchers identified a specific octopamine receptor (class 2) in locusts. This receptor exhibits characteristics typical of octopamine receptors, with potent agonists and antagonists identified.
Area of Science:
- Neuroscience
- Pharmacology
- Entomology
Background:
- Octopamine is a key neurotransmitter and neurohormone in invertebrates.
- Understanding octopamine receptors is crucial for insect neurobiology and pest control.
Purpose of the Study:
- To characterize the octopamine binding site in the nervous tissue of the migratory locust, Locusta migratoria.
- To determine the pharmacological properties of this binding site.
Main Methods:
- Radioligand binding assays using radiolabeled octopamine.
- Saturation analysis to determine binding site kinetics (KD, Bmax).
- Pharmacological profiling with various agonists and antagonists.
Main Results:
- The octopamine binding site was identified as an octopamine receptor of class 2.
- Binding was found to be saturable, reversible, and stereospecific.
- Saturation analysis revealed a single class of non-interacting binding sites with KD = 7.9 ± 0.9 nM and Bmax = 160 fmol/mg.
- Phenyliminoimidazolidines (NC7, NC5) were potent agonists (Ki = 0.29, 0.87 nM).
- Mianserin was identified as a potent antagonist (Ki = 1.20 nM).
Conclusions:
- The characterized binding site represents a class 2 octopamine receptor in Locusta migratoria.
- The identified agonists and antagonists provide valuable tools for studying octopamine receptor function.
- These findings contribute to the understanding of invertebrate neurotransmission and potential targets for insecticide development.
Related Concept Videos
Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Sympathetic Signaling
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Parasympathetic Signaling
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...

